We previously showed that codelivery of an rVCG vaccine co-expressing the CT major outer membrane protein (MOMP) and CTA2B, the non-toxic derivative of Ctx, significantly enhanced clearance of a C. muridarum vaginal infection following intravaginal immunization [43]. This evidence concerns the gene CYP27A1 and infective vaginitis.